UPDATE 1-FDA approves Pfizer's biosimilar to Roche's Herceptin
March 11, 2019 at 16:56 PM EDT
The U.S. Food and Drug Administration said on Monday it approved Pfizer Inc's biosimilar to Roche AG's blockbuster breast cancer treatment Herceptin.
